D'Onofrio Matthew J 4
4 · Evoke Pharma Inc · Filed Mar 3, 2025
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
D'Onofrio Matthew J
Exec VP, Chief Bus. Officer
Transactions
- Award
Common Stock
2025-02-28$3.65/sh+6,849$24,999→ 8,820 total
Footnotes (1)
- [F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(c) and Rule 16b-3(d).